Pharmacokinetic comparison of the vasorelaxant compound ferulic acid following the administration of Guanxin II to healthy volunteers and patients with angina pectoris

Abstract

Coronary heart disease (CHD) is the leading cause of mortality worldwide. The Chinese medicinal formula Guanxin II has been shown to have a favorable effect in the attenuation of angina. The aim of this study was to compare the pharmacokinetics of ferulic acid (FA), which is a vasorelaxant compound present in Guanxin II, in healthy volunteers and patients with angina pectoris following the administration of Guanxin II. Ex vivo experiments were performed in order to investigate the vasorelaxant effect of FA on the human internal mammary artery (IMA) to provide evidence that it is a bioactive component of Guanxin II. Following the oral administration of Guanxin II, the FA levels in the serum were quantified by a simple and rapid high-performance liquid chromatography (HPLC) method. Treatment with FA (10−8−10−3 M) caused a concentration-dependent relaxation of endothelial IMA rings following precontraction with KCl. Statistically significant differences were identified between the pharmaco-kinetic parameters Cmax, t1/2α, t1/2β and t1/2Ka of the healthy volunteers and the patients with angina pectoris following the oral administration of Guanxin II. FA is a bioactive compound absorbed from Guanxin II that attenuates angina pectoris, a condition that may modify the pharmacokinetics of FA. Not only do the pharmacokinetic parameters direct the clinical use of Guanxin II, but they may also be useful for exploring the pathology of angina pectoris.

Expression of microRNA-132 in patient with liver cancer and mediation of microRNA-132 on cell growth of liver cancer cell

“…It is positioned on chromosome 10 in rats while chromosome 11 and chromosome 17 are for mice and human beings, respectively (Maharshak et al, 2013). MiR-132 has tissue specificity and has high expressions in nerve- related tissues (Wang et al, 2013). It participates in axon growth, proliferation and differentiation of synapsis and formation of nerve tumors.…”

“…It was recognized early in 1993 (Zhang et al, 2014a). It is single structured and participates in essential biological functions such as cell development, apoptosis and metabolism, etc (Wang et al, 2013). As the important role of microRNA in some tumors has been confirmed, many scholars conducted initial studies on relationship between microRNA and occurrence, development and metastasis of liver cancer (Toffanin et al, 2011;.…”

“…In view of functional genomics and molecular pharmacology, pharmacogenomics is developed on the basis of pharmacogenetics at the end of 1990s and is an achievement of implementation of HGP (Vasku et al, 2009). Its main focus is to study pharmacogenetics by using results of genomics (Li et al, 2013). More specifically, it is to study the hereditary basis of polymorphism of drug reactions, to prove and explain modes of action as well as toxic and adverse effects of drug therapeutic effects and actions from the perspective of molecular level, which provides a platform to develop new drugs and guide rational drug use (Lam et al, 2013).…”

Angelica sinensis and osteoarthritis: A natural therapeutic link?

“…Few studies have been performed to date. Li et al [21] recently reported the pharmacokinetic parameters of ferulic acid in healthy volunteers. The results showed that SF was absorbed at a fast rate and rapidly eliminated (t 1/2 21 min).…”

Exploring potential biomarkers of coronary heart disease treated by Jing Zhi Guan Xin Pian using high-throughput metabolomics

“…It has the effect of anti-myocardial ischemic injury and inhibiting platelet aggregation. 7,8 JZGXP is made of Chinese herbal medicines such as red peony root, Salvia miltiorrhiza, chuanxiong, safflower and Lignum Dalbergiae Odoriferae. They have the function of promoting blood circulation and removing blood stasis and are used for chest sputum caused by internal hemorrhage.…”